Supply problems of unlicensed and off‐label medicines after discharge

Por Wong, I C K, Basra, N, Yeung, V W, Cope, Judith
Publicado em 2006

Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system

Por Man, K K C, Coghill, D, Chan, E W, Lau, W C Y, Hollis, C, Liddle, E, Banaschewski, T, McCarthy, S, Neubert, A, Sayal, K, Ip, P, Wong, I C K
Publicado no Transl Psychiatry (2016)

European guidelines on managing adverse effects of medication for ADHD

Por Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Döpfner, M., Hamilton, R., Hollis, C., Holtmann, M., Hulpke-Wette, M., Lecendreux, M., Rosenthal, E., Rothenberger, A., Santosh, P., Sergeant, J., Simonoff, E., Sonuga-Barke, E., Wong, I. C. K., Zuddas, A., Steinhausen, H.-C., Taylor, E.
Publicado em 2010